NCT00055445View on ClinicalTrials.gov

IdB 1016 Treatment for Hepatitis C Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

April 30, 2006

Conditions
Hepatitis C, Chronic
Interventions
DRUG

IdB 1016

Trial Locations (1)

98105

University of Washington Medical Center, Seattle

All Listed Sponsors
lead

National Center for Complementary and Integrative Health (NCCIH)

NIH

NCT00055445 - IdB 1016 Treatment for Hepatitis C Disease | Biotech Hunter | Biotech Hunter